Todd Young: “I hope no one is trying to take this away for campaign purposes.”

Without an industrious, innovative, and self-sustaining domestic biotechnology sector, the United States will remain at risk—both of relying on China for new, life-saving therapies and basic drugs, and of being unprepared for the next…

But it does require transparency, discipline, and a clear strategy to ensure any costs borne by Americans are tied to well-defined national security objectives.

America’s long-term economic strength depends on our ability to turn innovation into opportunity.

As we look ahead to the next 250 years, they will remain just as essential to America’s success.